Literature DB >> 8779278

[The interaction of hexamethonium derivatives with the cholinesterases of vertebrates and invertebrates. The physicochemical and conformational aspects].

E V Rozengart, N N Shestakova, S O Prokator, A E Khovanskikh, N N Kovalev, L M Epshteĭn.   

Abstract

Conformational and geometrical properties of the hexamethylenebis(trimethylammonium) (CH3)3N+-(CH2)6)-N+(CH3)3 (hexamethonium) and its derivatives with various degree of conformational flexibility of interonion chain having disulfide or two dimethylsilane groups or difluoromethylene chain instead of cholinesterase reversible inhibitors have been determined using molecular mechanics methods. Conformation-activity relationships between these inhibitors and different cholinesterases (human erythrocyte acetylcholinesterase, horse plasma butyrylcholinesterase, cholinesterase from the brain of the grass frog Rana temporaria and optical ganglia from the Pacific squid Todarodes pacificus and Comandor squids Berryteuthis magister from various areas) were investigated. Hypothesis of complex influence of conformational and geometrical properties (if molecules on anticholinesterase efficiency of compounds under investigation was formulated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8779278

Source DB:  PubMed          Journal:  Zh Evol Biokhim Fiziol        ISSN: 0044-4529


  3 in total

1.  Organofluoride ammonium compounds: a new group of reversible inhibitors of cholinesterases of various animals.

Authors:  E V Rozengart; N E Bassova
Journal:  Dokl Biochem Biophys       Date:  2003 Mar-Apr       Impact factor: 0.788

2.  Elementorganic bisonium reversible inhibitors of different cholinesterases.

Authors:  E V Rozengart; N E Basova
Journal:  Dokl Biochem Biophys       Date:  2004 Mar-Apr       Impact factor: 0.788

3.  Oligodimethylsiloxane reversible inhibitors of cholinesterases of some vertebrate and invertebrate animals.

Authors:  E V Rozengart; N E Basova
Journal:  Dokl Biochem Biophys       Date:  2010-08-17       Impact factor: 0.788

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.